• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconLeft Arrow Button IconPress Releases
Right Arrow Button Icon27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion
27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion
HACKENSACK, NJ
August 19, 2026, 3:44 PM ET
27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion / Source: Andreozzi + Foote (EZ Newswire)
27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion / Source: Andreozzi + Foote (EZ Newswire)

HACKENSACK, NJ, August 19, 2026 (EZ Newswire) -- 27 former patients of New Jersey physician Ritesh Kalra filed a civil lawsuit (Cause No: BER-L-007809-26) on Monday, August 17, 2026, alleging a years-long pattern of sexual abuse, exploitation, and other misconduct during medical appointments.

The lawsuit alleges that Kalra used his control over patients’ prescription medications as leverage, including by lowering medication doses after some patients allegedly resisted sexual advances.

The complaint, filed by Andreozzi and Foote in the Superior Court of New Jersey, Bergen County, names Ritesh Kalra, the doctor himself, Ritesh Kalra, MD, LLC, a limited liability company, and ten unidentified responsible individuals as defendants. The 27 plaintiffs include 24 women and three men.

According to the lawsuit, Kalra worked as an internist and provided primary care and pain-management services. He operated many offices throughout Bergen and Hudson County, including but not limited to Fairlawn, Jersey City, and Secaucus.

“The complaint alleges that Kalra sexually exploited patients who depended on him for medical care and, in some instances, used control over their prescription medication as a means of coercion or retaliation,” said Nathaniel Foote, Partner at Andreozzi + Foote. “Our clients are seeking accountability through the civil justice system, and we intend to pursue these claims on their behalf.

Kalra is awaiting trial on a separate 58-count federal indictment that includes 36 counts of unlawful distribution of controlled substances, one count of maintaining a drug-involved premises, and 21 counts of health care fraud. According to federal court records, between January 2019 and February 2025, Kalra issued approximately 31,289 oxycodone prescriptions to more than 1,500 patients. The civil complaint states that the federal investigation also found that Kalra demanded sexual favors from patients to obtain prescriptions.

The New Jersey State Board of Medical Examiners also suspended Kalra’s medical license and CDS (Controlled Dangerous Substances) registration in August 2025, citing allegations of indiscriminate prescribing and prescribing CDS without a legitimate medical purpose.

The plaintiffs seek compensatory and punitive damages and have demanded a jury trial.

About Andreozzi + Foote

Andreozzi + Foote is one of the nation’s leading sexual abuse law firms with a history of representing survivors in cases against large and powerful organizations including Penn State University, the Boy Scouts of America, and the Catholic Church. The trauma-informed sexual abuse lawyers at Andreozzi + Foote are committed to obtaining life-changing results for victims and their families. For more information, visit www.victimscivilattorneys.com.

Media Contact

Andreozzi + Foote
marias@vca.law
+1 717-807-5808

###

SOURCE: Andreozzi + Foote

For questions regarding this release or its content, contact hello@eznewswire.com for immediate assistance.

About the Author
By EZ Newswire
See full bioRight Arrow Button Icon
Share this article
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.